Controversies exist in the management of chronic kidney disease and comorbidities. Do you think the currently available clinical practice guidelines sufficiently address these controversies?
The Global Initiative for Chronic Obstructive Pulmonary Disease outlines the benefits of a LAMA/LABA combination therapy. Do you think the combination should be used as an initial maintenance treatment for...